
Deals
SRX Global Agrees to Buy Cell Therapy Developer CERo Therapeutics
A special purpose vehicle, CERO 1236, will raise money directly into the subsidiary so existing SRX shareholders are not diluted, the company said.
Bootstrapped Wealth reported on CERo Therapeutics Holdings, Inc. on October 7, 2026.
October 7, 2026
The target is the operating business of CERo Therapeutics Holdings Inc., which trades on the OTCQB market under CERO.

Deals
A special purpose vehicle, CERO 1236, will raise money directly into the subsidiary so existing SRX shareholders are not diluted, the company said.